# Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/telitacicept-in-patients-with-active-systemic-lupus-erythematosus-results-of-a/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Di Wu,Jing Li,Dong Xu,Joan T. Merrill,Ronald van Vollenhoven,Yi Liu,Jiankang Hu,Yang Li,Fen Li,Chenghui Huang,Guochun Wang,Xiaomei Li,Jianhong Zhao,Dongbao Zhao,Cibo Huang,Huaxiang Liu,Wei Wei,Guixiu Shi,Fuai Lu,Xiaoxia Zuo,Liqi Bi,Zhijun Li,Xiaoxia Wang,Miaojia Zhang,Ning Tie,Juan Li,Hanyou Mo,Jianmin Fang,Chunde Bao,Fengchun Zhang |
| Citations | 146 |
| DOI | 10.1136/ard-2023-224854 |
| Fields | Biochemistry, Genetics and Molecular Biology,Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ard.bmj.com/content/annrheumdis/early/2023/12/21/ard-2023-224854.full.pdf |
| OpenAlex ID | https://openalex.org/W4390047658 |
| PMID | 38129117 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Fengchun Zhang](https://scholariq.org/researchers/fengchun-zhang/)

## Paper journal

- [Annals of the Rheumatic Diseases](https://scholariq.org/journals/annals-of-the-rheumatic-diseases/)

## Paper primary topic

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Paper topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Diabetes and associated disorders](https://scholariq.org/topics/diabetes-and-associated-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.